Medicinal Cannabis Shows Little Efficacy for Common Mental Health Disorders, Landmark Study Finds
A groundbreaking meta-analysis published in The Lancet, the most comprehensive examination to date of medicinal cannabis across a spectrum of…
A Landmark Study in The Lancet Reveals Medicinal Cannabis Ineffective for Common Mental Health Disorders
A groundbreaking systematic review and meta-analysis, published in the prestigious medical journal The Lancet, has delivered a significant blow to…
Medicinal Cannabis Shows No Efficacy for Anxiety, Depression, or PTSD in Landmark Lancet Study
A groundbreaking systematic review and meta-analysis published in the prestigious medical journal The Lancet has delivered a stark verdict on…
MHRA Launches Comprehensive Investigation Into UK Clinics Promoting Unregulated Experimental Peptides and Unauthorized Medicinal Claims
The Medicines and Healthcare products Regulatory Agency (MHRA) has formally initiated an investigation into several private health clinics across the…
A Landmark Study in The Lancet Reveals Medicinal Cannabis Lacks Efficacy for Common Mental Health Conditions
A groundbreaking meta-analysis published in the esteemed medical journal The Lancet has delivered a significant blow to the widespread perception…
Medicinal Cannabis Falls Short in Treating Common Mental Health Conditions, Landmark Lancet Study Reveals
A comprehensive and groundbreaking analysis published in the esteemed medical journal The Lancet has delivered a significant blow to the…
Medicinal Cannabis Ineffective for Anxiety, Depression, and PTSD, Landmark Study Finds
A groundbreaking analysis published in the prestigious medical journal The Lancet has delivered a significant blow to the widespread belief…
Medicinal Cannabis Ineffective for Common Mental Health Conditions, Landmark Study Finds
A comprehensive and groundbreaking analysis published in the esteemed medical journal The Lancet has delivered a significant blow to the…
European Medicines Agency Initiates Standardized Framework for Non-Clinical Evaluation of Microbiome-Based Medicinal Products
The European Medicines Agency (EMA), acting through its Committee for Medicinal Products for Human Use (CHMP), has formally announced the…
